PATRICIA MCGRAIL: Open Payments
NPI 1801428974 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,096 in 49 payments from 14 companies in 2025. Trend: 2023 $2,676 · 2024 $1,490 · 2025 $1,096
Food & beverage: $1,096
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 8 | $176 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $126 |
| PFIZER INC. | 7 | $124 |
| Boston Scientific Corporation | 3 | $102 |
| Lundbeck LLC | 3 | $99 |
| ABBVIE INC. | 4 | $97 |
| IBSA Pharma Inc. | 5 | $96 |
| Axsome Therapeutics, Inc. | 5 | $95 |
| SI-BONE, INC. | 2 | $54 |
| Forte Bio-Pharma LLC | 2 | $47 |
Products named: Belbuca, RELISTOR, NURTEC ODT, WaveWriter Alpha Prime 16, VYEPTI, Tirosint, Symbravo, UBRELVY.
Industry payments across NC — which companies pay providers there.
